Market revenue in 2024 | USD 390.2 million |
Market revenue in 2030 | USD 742.6 million |
Growth rate | 11.3% (CAGR from 2024 to 2030) |
Largest segment | Adult stem cells |
Fastest growing segment | Induced Pluripotent Stem Cells |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells |
Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stem cells market will help companies and investors design strategic landscapes.
Adult stem cells was the largest segment with a revenue share of 83.83% in 2024. Horizon Databook has segmented the Brazil stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
Stem cell research is regulated by The Biosafety Act 2005 in Brazil. In May 2016, the Federal Government enacted new genetic heritage access law. With the compliance of this law, the government enabled access to genetic heritage and protection of associated traditional knowledge to provide benefit-sharing for sustainable use and conservation of diversity in the country.
According to collaborative research by Brazilian institutions, including the Institute of Advanced Systems in Health, Oswaldo Cruz Foundation, Federal University of Bahia, and AMO Clinic/Etica Institute, in February 2022, the International Society for Stem Cell Research recommended establishing universal standards to control quality in stem cell manufacturing.
The specifications are product specific and involve information on purity, cell viability, impurities, identity, and the total number of cells, which should be considered important parameters for the use of MSCs in therapeutic applications. Changes in biosafety law with better clarity are anticipated to drive the adoption of stem cell research, thereby expected to boost the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil stem cells market , including forecasts for subscribers. This country databook contains high-level insights into Brazil stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account